EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Screening and treatment of latent tuberculosis in patients with solid tumors and systemic cancer therapy

Miguel Borregón, David Sánchez, Elia Martínez

Clinical and Translational Oncology · 2024

DOI: 10.1007/s12094-024-03433-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Translational Oncology, 2024. Verfasst von Miguel Borregón und 2 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Oncología Médica del Hospital General Universitario de Elche, Carrer Almazara, 11, 03203, Elche, Alicante, Spain. miguelborregonrivilla@g…. Hauptthemen laut MEDLINE: Neoplasms, Latent Tuberculosis, Practice Guidelines as Topic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Tuberculosis is one of the infectious diseases with greater morbidity and mortality worldwide. Cancer causes an important immunosuppression with increased risk of infections. There is an enlarged bidirectional incidence between tuberculosis and cancer, mainly due to latent tuberculosis. GUIDELINES REVIEW: There is great discrepancy between recommendations for screening and prophylaxis of latent tuberculosis in patients with solid tumors and systemic cancer therapy among different medical societies and guidelines. Most infectious diseases guidelines recommend it, while most oncology guidelines do not. DISCUSSION: Patients with solid tumours generally have a limited life expectancy and a state of intermittent immunosuppression, resulting in a lower risk of tuberculosis reactivation than other risky populations. There is a lack of prospective and retrospective studies analysing the benefit of screening and prophylaxis in this population. The first step is to study the incidence of active tuberculosis in this population to estimate the real magnitude of the problem.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsLatent TuberculosisPractice Guidelines as TopicHumansAntitubercular AgentsIncidenceMass ScreeningImmunocompromised HostAntineoplastic Agents

Stichwörter der Autor:innen

GuidelinesProphylaxisScreeningSolid tumoursSystemic cancer therapyTuberculosis

Substanzen

Antitubercular AgentsAntineoplastic Agents

Autor:innen und Institutionen

  • Servicio de Oncología Médica del Hospital General Universitario de Elche, Carrer Almazara, 11, 03203, Elche, Alicante, Spain. miguelborregonrivilla@gmail.com.
  • Servicio de Oncología Médica del Hospital General Universitario de Elche, Carrer Almazara, 11, 03203, Elche, Alicante, Spain.
  • Servicio de Oncología Médica del Hospital Universitario de Fuenlabrada, Madrid, Spain.

Zitieren

APA

Borregón, M., Sánchez, D., & Martínez, E. (2024). Screening and treatment of latent tuberculosis in patients with solid tumors and systemic cancer therapy. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03433-4

Vancouver

Borregón M, Sánchez D, Martínez E. Screening and treatment of latent tuberculosis in patients with solid tumors and systemic cancer therapy. Clinical and Translational Oncology. 2024. doi:10.1007/s12094-024-03433-4

BibTeX
@article{Borregn2024,
  author = {Borregón, Miguel and Sánchez, David and Martínez, Elia},
  title = {Screening and treatment of latent tuberculosis in patients with solid tumors and systemic cancer therapy},
  journal = {Clinical and Translational Oncology},
  year = {2024},
  doi = {10.1007/s12094-024-03433-4}
}
Kostenlos starten →